Lahore: Liven Pharma Limited has announced that its Board of Directors will convene on October 2, 2026, at 4:00 PM via a Zoom meeting to deliberate on the company's Annual Accounts for the fiscal year ending June 30, 2026. The meeting will also consider any possible declaration of entitlement, as confirmed in the company's latest report dated September 25, 2026.

In compliance with PSX Regulations 5.6.1(d), Liven Pharma Limited has instituted a Closed Period starting from September 25, 2026, through October 2, 2026. During this time frame, no Director, CEO, or Executive associated with the company is permitted to engage, either directly or indirectly, in any transactions involving the company’s shares.

According to information available from the Pakistan Stock Exchange (PSX), the Closed Period is a regulatory requirement meant to prevent any potential conflicts of interest or misuse of insider information prior to the public disclosure of financial results.

The company's communication also includes a directive to inform the TRE Certificate Holders of the Exchange about these developments, ensuring transparency and adherence to market regulations.